CVR 43134477Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København VFounded 18 Mar 2022
Employees
6
CVR registry, Aug 2026
0 (0%) over 12 months
Gross profit
-2.1M
DKK, annual report 2025
Result
-2.6M
DKK, annual report 2025
Equity
5.2M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Chosa ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexChosa Oncology AB100% of capital and votes, since 18 Jan 2023
Claus Frisenberg Pedersensince 6 May 2022
Peter Buhlsince 18 Mar 2022
100% of capital and votessince 18 Jan 2023
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2556973333.3% to under 50% of capital and votes18 Mar 2022 to 18 Jan 2023
CVR 327777755% to under 10% of capital and votes18 Mar 2022 to 16 Jan 2023
CVR 3870735315% to under 20% of capital and votes18 Mar 2022 to 18 Jan 2023
CVR 4169702410% to under 15% of capital and votes18 Mar 2022 to 18 Jan 2023
5% to under 10% of capital and votes18 Nov 2022 to 18 Jan 2023
5% to under 10% of capital and votes18 Mar 2022 to 16 Jan 2023
10% to under 15% of capital and votes18 Nov 2022 to 18 Jan 2023
CVR records founders at incorporation. It does not record whether they are alive or still involved.
18 Mar 2022 to 3 Nov 2026.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Gross profit | -467 | -1,543 | Not reported | -2,136 |
| Operating profit | -817 | -2,043 | -2,373 | -3,347 |
| Result for the year | -715 | -2,070 | -3,587 | -2,632 |
| Equity | 7,761 | 8,991 | 7,485 | 5,175 |
| Total assets | 7,949 | 10,295 | 11,189 | 13,427 |
| Employees (average) | 0 | 0 | 1 | 0 |
| Credit metrics (Dandex calculations) | ||||
| EBITDA | -467 | -1,543 | -1,206 | -2,847 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -645note 1 | -518note 1 | 4 | -953 |
| ROIC (afkast af investeret kapital) | Not reportednote 2 | -20.4%note 3 | -23.2%note 4 | -43.4%note 4 |
| Capex (investeringer i anlægsaktiver) | Not reportednote 5 | 0note 6 | 2,667note 6 | 3,156note 6 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -636note 1 | -2,285note 1 | 492 | 5,200 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. Not every period is a full year: 2022 covers 9 months (18 Mar to 31 Dec 2022). Changes against it compare periods of different length.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
1 registered in CVR.
P-number 1028094775Puggaardsgade 17, 1573 København V
